Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piracetam added to vestibular rehabilitation for chronic peripheral vertigo
2005-005460-80Phase 2Active
- Sponsor
- N/A
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of piracetam in Peripheral vertigo (2 arms), sponsored by N/A. Primary endpoints: Relief of patient symptomatology and Change in abnormal neuro-otological findings. Started Dec 2006; status: active.
02
Drugs
piracetam
03
Conditions
Peripheral vertigo
Beyond the preview
Go deeper on 2005-005460-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005460-80.